Core Scientific, Inc./tx (CORZ)
Core Scientific, Inc./tx (CORZ) from its SEC filings: 2025 revenue $319.0 million (-38% vs the year before), net margin -90%, free cash flow -$450.8 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Finance Services |
| Revenue (2025) | $319.0 million |
| Revenue growth | -38% |
| Net income | -$288.6 million |
| Net margin | -90.5% |
| Free cash flow | -$450.8 million |
| Diluted EPS | $-0.88 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +109% |
| Cash | $1.8 billion |
| Long-term debt | $4.3 billion |
| Share count, 1 year | +5% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.